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Cognitive Functioning and Depression 1 
Is Low Cognitive Functioning a Predictor or Consequence of Major Depressive Disorder? 
A Test in Two Longitudinal Birth Cohorts 
ABSTRACT 
Cognitive impairment has been identified as an important aspect of major depressive 
disorder (MDD). We tested two theories regarding the association between MDD and cognitive 
functioning using data from longitudinal cohort studies. One theory, the “cognitive reserve 
hypothesis,” suggests that higher cognitive ability in childhood decreases risk of later MDD. The 
second, the “scarring hypothesis,” instead suggests that MDD leads to persistent cognitive 
deficits following disorder onset. We tested both theories in the Dunedin Study, a population-
representative cohort followed from birth to midlife and assessed repeatedly for both cognitive 
functioning and psychopathology. We also used data from the E-Risk Study to test whether 
childhood cognitive functioning predicts future MDD risk independent of family-wide and 
genetic risk using a discordant twin design. Contrary to both hypotheses, we found that 
childhood cognitive functioning did not predict future risk of MDD, nor did Study members with 
a past history of MDD show evidence of greater cognitive decline unless MDD was 
accompanied by other comorbid psychiatric conditions. Our results thus suggest that low 
cognitive functioning is related to comorbidity, but is neither an antecedent nor enduring 
consequence of MDD. Future research may benefit from considering cognitive deficits that occur 
during depressive episodes from a transdiagnostic perspective. 
Keywords: intelligence, depression, cognitive reserve, cognitive scarring, cognitive functioning 
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INTRODUCTION 
Major depressive disorder (MDD) is the most common of all psychiatric disorders and a 
leading cause of disability worldwide (Whiteford et al., 2013). Although lifetime prevalence 
rates generated by cross-sectional epidemiologic surveys suggest that roughly a third of a 
population will develop MDD at some point during the life course (Kessler et al., 2005), 
corresponding figures drawn from longitudinal studies suggest that the true lifetime prevalence 
of the disorder may be substantially higher (Farmer, Kosty, Seeley, Olino, & Lewinsohn, 2013; 
Moffitt et al., 2010; Schaefer et al., 2017). This high prevalence is concerning, as MDD has been 
shown to predict lower life expectancy, increased susceptibility and risk of mortality from 
physical disease, and higher risk of suicide (Cassano & Fava, 2002). MDD also negatively 
affects multiple measures of occupational and interpersonal functioning (Adler et al., 2006; 
Hirschfeld et al., 2000). 
Interestingly, many of these functional impairments associated with MDD have been 
shown to persist even after patients’ depressed mood has remitted (Kennedy, Foy, Sherazi, 
McDonough, & McKeon, 2007), suggesting that non-affective factors may play a critical role in 
determining functional outcomes. One such well-established predictor of overall functioning is 
cognitive functioning. Although deficits in the ability to think or concentrate have been listed 
among the diagnostic criteria for MDD since the term “major depressive disorder” was first 
introduced in the mid-1970s (Philipp, Maier, & Delmo, 1991), substantial interest in the 
treatment of cognitive impairment in the context of MDD has emerged more recently. For 
example, the National Academies of Sciences have hosted several workshops focused on 
understanding and treating cognitive dysfunction in depression in recent years (National 
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Academies of Sciences, Engineering, and Medicine, 2015), and the Food & Drug Administration 
(FDA) is now considering proposals to approve drugs that specifically target cognitive deficits 
associated with depression (Ledford, 2016; Mullard, 2016). These initiatives have been 
motivated by a number of cross-sectional reviews and meta-analyses on MDD, which report (1) 
that depressed individuals score lower than healthy controls across a wide variety of cognitive 
tasks (Christensen, Griffiths, Mackinnon, & Jacomb, 1997; Rock, Roiser, Riedel, & Blackwell, 
2014; Rogers et al., 2004; Snyder, 2013), even at first episode (Lee, Hermens, Porter, & 
Redoblado-Hodge, 2012), and (2) that these deficits can be observed even in individuals whose 
depression has remitted (Bora, Harrison, Yücel, & Pantelis, 2013; Rock et al., 2014). Greater 
cognitive deficits in the context of MDD, in turn, are associated with increased symptom severity 
(McDermott & Ebmeier, 2009), higher rates of relapse and recurrence (Majer et al., 2004), and 
impaired functioning after discharge from psychiatric hospitalization (Jaeger, Berns, Uzelac, & 
Davis-Conway, 2006). Consequently, there is now considerable interest in the identification of 
novel therapeutic agents capable of bringing about “cognitive remission” in depressed patients 
(Bortolato et al., 2016; Ledford, 2016), in addition to the remission of affective symptoms. 
Before recommending that cognitive impairment in MDD should become a target of 
treatment, however, it is important to understand the origin and developmental course of these 
deficits. To date, two theoretical models have been proposed to explain the relationship between 
persistent cognitive impairments and MDD. The first, called the “cognitive reserve hypothesis,” 
suggests that individuals with high intelligence are simply less likely to develop depression, 
either due to superior neural integrity or an increased ability to cope with or avoid stressful 
situations (Barnett, Salmond, Jones, & Sahakian, 2006; Koenen et al., 2009; Salmond, Menon, 
Chatfield, Pickard, & Sahakian, 2006; Scult, Knodt, Swartz, Brigidi, & Hariri, 2016). Thus, 
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cognitive “deficits” seen in cross-sectional studies that compare the cognitive performance of 
depressed or remitted individuals to healthy volunteers would be an indicator of “trait-like” 
differences that present early in development, well before MDD onset.  This model draws 
support from a number of longitudinal studies documenting that low intelligence at time 1 is a 
robust predictor of subsequent depression at time 2, summarized in a recent meta-analysis (Scult 
et al., 2017). Scult et al. (2017) note, however, that the majority of the studies demonstrating a 
predictive association between intelligence and MDD appear to be driven by depressive 
symptoms already present at the time of baseline cognitive assessment. 
A second explanatory model, termed the “scarring hypothesis,” suggests that the 
cognitive deficits observed in depressed patients result from enduring changes in physiology and 
neurochemistry that begin around the time of MDD onset and impair cognitive functioning from 
that point forward (Lewinsohn, Steinmetz, Larson, & Franklin, 1981). In this model, cognitive 
impairment in the context of MDD falls somewhere between “trait” and “state” factors. Although 
cognitive deficits are not proposed to precede the onset of depressive symptoms, they are 
hypothesized to persist well after the resolution of affective symptoms, potentially leaving MDD 
patients with a lifelong (albeit mild) impairment. 
Although both of these models have been supported by previous research, the existing 
body of literature on persistent cognitive deficits in MDD is characterized by at least four 
important limitations. First, many of the studies that report associations between MDD and 
cognitive functioning have used small, clinical samples. Because depressed individuals receiving 
psychiatric care may differ from those who are not in several significant ways, the 
generalizability of these findings to the larger population of depressed individuals is unclear. 
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This possibility is underscored by a recent study using population-representative data from the 
National Comorbidity Survey Adolescent Supplement (NCS-A), which reported that adolescents 
with past-year depression or dysthymia scored higher (rather than lower) on a measure of fluid 
intelligence compared to peers with no distress disorders (Keyes, Platt, Kaufman, & 
McLaughlin, 2016).  
Second, the majority of studies that report associations between IQ and MDD have 
assessed MDD at only a single time point. However, multiple psychiatric assessments are 
desirable in this context because longitudinal studies that have calculated the lifetime prevalence 
of MDD using both single and repeated assessments have generally found that repeated 
assessments generate 2.5 to 3 times higher prevalence estimates (Moffitt et al., 2010; Takayanagi 
et al., 2014). Thus, studies that use cognitive functioning to predict MDD at a single point in 
time are more likely to miscategorize individuals who have experienced or will experience 
depression as “healthy controls,” potentially biasing estimates of effect size. 
Third, it is also desirable to analyze data drawn from studies with multiple cognitive 
assessments, particularly when evaluating participants for evidence of cognitive “scarring”. 
Despite this, the majority of studies that examine associations between cognitive performance 
and remitted depression are cross-sectional in nature, making it difficult to determine whether or 
not observed deficits represent a true decline from baseline ability following a depressive 
episode.  
Fourth, relatively few studies of the link between IQ and MDD have taken rigorous steps 
to account for the presence or absence of comorbid diagnoses in diagnostic groups (see Scult et 
al., 2017), and those that have assessed participants for comorbidity have tended to use a single 
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assessment wave (Snyder, 2013). These designs limit interpretation of previous findings, as prior 
work has shown that many psychiatric disorders apart from MDD are predicted prospectively by 
low IQ (Batty, Mortensen, & Osler, 2005; Gale et al., 2010; Gale et al., 2008), associated with 
contemporaneous impairments in cognitive test performance (Airaksinen, Larsson, & Forsell, 
2005; Horner & Hamner, 2002; Muller & Roberts, 2005; Schaefer, Giangrande, Weinberger, & 
Dickinson, 2013), and associated with cognitive “scarring” that lingers after symptomatic 
remission (Mann-Wrobel, Carreno, & Dickinson, 2011; Meier et al., 2012, 2014; Stavro, 
Pelletier, & Potvin, 2013). This raises the possibility that observed deficits thought to be 
associated with MDD are, in fact, driven by either unobserved comorbidities or some shared, 
transdiagnostic process.  
To address these limitations, we present tests of both the cognitive reserve and scarring 
hypotheses using data drawn from two population-representative, longitudinal studies. The first 
sample, the Dunedin Study, follows a population-representative cohort from birth to midlife, 
with IQ tests administered at ages 7, 9, 11, and 38 years, and neuropsychological testing 
conducted at ages 13 and 38. At age 38, Dunedin Study members were also administered a set of 
self- and informant-report questionnaires asking questions about perceived cognitive functioning. 
In addition, Dunedin Study members completed psychiatric interviews assessing them for a 
variety of common psychiatric disorders every few years starting at age 11.  
Over its course, the Dunedin Study also assessed Study members for a number of clinical 
indicators relevant to MDD, including disorder age of onset, persistence/recurrence of depressive 
episodes, self-rated impairment due to MDD, number of MDD diagnostic criteria endorsed, 
whether the Study member received clinical attention for their MDD, and psychiatric 
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comorbidity. We used these variables to test whether evidence of cognitive reserve or scarring is 
especially pronounced among Study members with particularly early-onset, severe, comorbid, or 
otherwise extreme cases of MDD. 
Our second sample, the Environmental Risk (E-Risk) Longitudinal Twin Study, follows a 
cohort of twins born in the U.K. from birth to age 18 years, with IQ tests administered at age 12 
and a single psychiatric assessment using DSM criteria administered at age 18 years. We used 
the E-Risk Study’s twin design to examine whether the lower-IQ member of each twin pair was 
at relatively elevated risk of receiving a depression diagnosis at age 18. Because this design 
controls for shared environmental and (in monozygotic twin pairs) genetic factors that might 
normally account for an association between IQ and MDD, a positive finding would indicate that 
lower IQ predicts risk of MDD independent of these factors, providing support for a causal 
relationship. 
METHODS 
 Because our article makes use of data drawn from two different longitudinal studies, we 
have divided the methods section into two parts. Part I describes the assessment of IQ and mental 
disorder in the Dunedin Study, whereas Part II describes how these same constructs were 
assessed in the E-Risk Study. A description of the neuropsychological measures administered to 
Dunedin Study members at ages 13 and 38 can be found in the Supplementary Materials. 
I. The Dunedin Study 
Sample 
The Dunedin Multidisciplinary Health and Development Study is a 4-decade, 
longitudinal investigation of health and behavior in a population-representative birth cohort. 
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Study members (N = 1,037; 91% of eligible births; 52% male) were all individuals born between 
April 1972 and March 1973 in Dunedin, New Zealand who were eligible for the longitudinal 
study based on residence in the province at age 3, and who participated in the first follow-up 
assessment at age 3. The cohort represents the full range of socioeconomic status on New 
Zealand’s South Island. In adulthood, the cohort matches the New Zealand National Health and 
Nutrition Survey on health indicators (e.g., BMI, smoking, GP visits) (Poulton, Moffitt, & Silva, 
2015). The cohort is primarily white; fewer than 7% self-identify as having partial non-
Caucasian ancestry. Assessments were carried out at birth and at ages 3, 5, 7, 9, 11, 13, 15, 18, 
21, 26, 32, and, most recently, 38 years, when 95% of the 1,007 Study Members still alive took 
part. At each assessment wave, each Study member is brought to the Dunedin research unit for a 
full day of interviews and examinations. The Otago Ethics Committee approved each phase of 
the Study and informed consent was obtained from all Study members. 
Measures of Intelligence (IQ) 
Childhood intelligence. We report results from the Wechsler Intelligence Scale for 
Children—Revised (WISC-R; Wechsler, 1974), using participants’ total scores averaged over the 
three assessment points at ages 7, 9, and 11 to represent intelligence in childhood. 
Adult intelligence. We report results from the Wechsler Adult Intelligence Scale, 4th 
Edition (WAIS-IV; Wechsler, 2008), administered at age 38.  
Self-reported cognitive functioning 
 At age 38, Study members were queried about problems related to memory and attention. 
Study members reported how often in the past year (never, sometimes, or often) they 
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experienced problems with keeping track of appointments, remembering why they went to a 
store, and repeating the same story to someone, among other items. Scores on each of the 17 
questions were summed to create an overall measure of cognitive difficulties (M = 9.1; SD = 5.3; 
range = 0-31; internal consistency reliability = 0.83). Study members were also asked to rate the 
extent to which their cognitive difficulties interfered with their lives on a scale from 1 (some 
impairment) to 5 (severe impairment). Both self-reported cognitive difficulties (r = -0.15) and the 
extent of impairment (r = -0.16) were negatively correlated with adult full-scale IQ (both p’s < 
0.0001).  
Informant-reported cognitive problems 
Informant reports of Study members’ cognitive function were obtained at age 38. Study 
members nominated people who “knew them well.” These informants were mailed 
questionnaires and asked to complete a checklist, including whether the Study member had 
problems with his or her attention and memory over the past year. The informant-reported 
attention problems scale consisted of four items: “Is easily distracted, gets side-tracked easily,” 
“Can’t concentrate, mind wanders,” “Tunes out instead of focusing,” and “Has difficulty 
organizing tasks that have many steps” (internal consistency reliability = 0.79). The informant-
reported memory problems scale consisted of three items: “Has problems with memory,” 
“Misplaces wallet, keys, eyeglasses, paperwork,” and “Forgets to do errands, return calls, pay 
bills” (internal consistency reliability = 0.64). Both informant-reported attention problems (r = -
0.26) and informant-reported memory problems (r = -0.14) were negatively correlated with adult 
full-scale IQ (both p’s < 0.0001).  
Assessment of Mental Disorders 
Cognitive Functioning and Depression 10 
Mental disorders were ascertained in the Dunedin Study longitudinally using a periodic 
sampling strategy: Every 2 to 6 years, Study members were interviewed about past-year 
symptoms in a private in-person interview at the research unit by trained interviewers with 
tertiary qualifications and clinical experience in a mental health-related field such as family 
medicine, clinical psychology, or psychiatric social work (i.e. not lay interviewers). Interviewers 
used the Diagnostic Interview Schedule for Children (DIS-C) at the younger ages (11-15 years) 
and the Diagnostic Interview Schedule at the older ages (18-38 years). At each assessment, 
interviewers were kept blind to Study members’ previous data, including mental health status. At 
ages 11, 13, and 15, diagnoses were made according to the then-current DSM-III and grouped for 
this article into a single wave reflecting the presence or absence of specific juvenile mental 
disorders. At ages 18 and 21, diagnoses were made according to the DSM-III-R (APA, 1987), 
and at ages 26, 32, and 38 diagnoses were made according to the DSM-IV (APA, 1994). This 
method led to 6 waves in total representing ages 11-15, 18, 21, 26, 32, and 38. In addition to 
symptom criteria, diagnosis required impairment ratings for that disorder ≥ 2 on a scale from 1 
(some impairment) to 5 (severe impairment). Each disorder was diagnosed regardless of the 
presence of other disorders. Variable construction details, reliability and validity, and evidence 
of life impairment for diagnoses have been reported previously (Feehan, McGee, Raja, & 
Williams, 1994; Kim-Cohen et al., 2003; Moffitt et al., 2007, 2010; Newman et al., 1996). 
II. The Environmental Risk (E-Risk) Cohort
Sample 
Participants were members of the Environmental Risk (E-Risk) Longitudinal Twin Study, 
a birth cohort of 2,232 British children. The sample was drawn from a larger birth register of 
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twins born in England and Wales from 1994-1995 (Trouton, Spinath, & Plomin, 2002). Full 
details on the sample have been previously reported (Moffitt & the E-Risk Study Team, 2002). 
Briefly, the E-Risk sample was constructed in 1999–2000, when 1,116 families (93% of those 
eligible) with same-sex 5-year-old twins participated in home-visit assessments. This sample 
comprised 56% monozygotic (MZ) and 44% dizygotic (DZ) twin pairs. Within zygosity, 48% of 
MZ twins were male, and 50% of DZ twins were male. Families were recruited to represent the 
UK population of families with newborns in the 1990s, on the basis of residential location 
throughout England and Wales and mother's age. Teenaged mothers with twins were over-
selected to replace high-risk families who were selectively lost to the register through 
nonresponse. Older mothers having twins via assisted reproduction were under-selected to avoid 
an excess of well-educated older mothers. The study sample represents the full range of 
socioeconomic conditions in Great Britain, as reflected in the families’ distribution on a 
neighborhood-level socioeconomic index (ACORN [A Classification of Residential 
Neighborhoods], developed by CACI Inc. for commercial use) (Odgers, Caspi, Bates, Sampson, 
& Moffitt, 2012): 25.6% of E-Risk families live in “wealthy achiever” neighborhoods compared 
to 25.3% nationwide; 5.3% vs. 11.6% live in “urban prosperity” neighborhoods; 29.6% vs. 
26.9% live in “comfortably off” neighborhoods; 13.4% vs. 13.9% live in “moderate means” 
neighborhoods; and 26.1% vs. 20.7% live in “hard-pressed” neighborhoods. E-Risk 
underrepresents “urban prosperity” neighborhoods because such households are likely to be 
childless.   
Follow-up home visits were conducted when the children were aged 7 (98% 
participation), 10 (96% participation), 12 (96% participation), and, most recently in 2012–2014, 
18 years (93% participation). There were 2,066 children who participated in the E-Risk 
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assessments at age 18, and the proportions of MZ (56%) and male same-sex (47%) twins were 
almost identical to those found in the original sample at age 5. The average age of the twins at 
the time of the assessment was 18.4 years (SD = 0.36); all interviews were conducted after the 
18th birthday. Home visits at ages 5, 7, 10, and 12 years included assessments with participants 
as well as their mother (or primary caretaker); the home visit at age 18 included interviews only 
with the participants. Each twin participant was assessed by a different interviewer.  
The Joint South London, Maudsley, and the Institute of Psychiatry Research Ethics 
Committee approved each phase of the study. Parents gave informed consent and twins gave 
assent between 5 and 12 years and then informed consent at age 18. 
Measure of Intelligence (IQ) 
Childhood intelligence. We administered a short version of the Wechsler Intelligence 
Scale for Children-Revised (WISC-R) when Study members were age 12 years. Using two 
subtests (Matrix Reasoning and Information), we prorated Study members’ IQs and standardized 
them to M = 100 (SD = 15), according to the method recommended by Sattler (2008). 
Assessment of Depression 
Unlike the Dunedin cohort, which underwent repeated diagnostic assessments from age 
11 to 38, the E-Risk Study members participated in only one diagnostic interview at age 18, 
during which they were assessed for past-year DSM-IV symptoms of MDD using the Diagnostic 
Interview Schedule (DIS) (Robins, Cottler, Bucholz, & Compton, 1995). As in the Dunedin 
Study, E-Risk Study members meeting symptom criteria for MDD also needed to report 
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impairment ratings ≥ 2 on a scale from 1 (some impairment) to 5 (severe impairment) to receive 
a diagnosis. 
RESULTS 
We present results in three parts. Part I presents our tests of the cognitive reserve 
hypothesis, in which lower IQ in childhood is hypothesized to predict an increased risk of 
subsequent MDD. Part II presents our tests of the scarring hypothesis, in which IQ deficits are 
hypothesized to persist in individuals with a history of MDD, even after remission of their 
affective symptoms. Finally, Part III extends both of these analyses to neuropsychological 
measures assessing memory and executive functioning, two domains that have been repeatedly 
linked to MDD in previous work (Bora et al., 2013; Hsu & Davison, 2017; Rock et al., 2014).  
I. The Cognitive Reserve Hypothesis 
Does lower IQ in childhood predict increased risk of developing Major Depressive Disorder? 
To address this question, we started with 957 (92.3%) of the original 1,037 Dunedin 
Study members, including only those individuals who (a) had participated in at least half of the 
six mental health assessment waves from ages 11 to 38 and (b) had available childhood IQ data. 
Because schizophrenia is often accompanied by depression, and is associated with pronounced 
pre-morbid and post-onset cognitive deficits as well as thought disorder symptoms (Kendler, 
Ohlsson, Sundquist, & Sundquist, 2014; Meier et al., 2014; Reichenberg et al., 2010; Schaefer et 
al., 2013), we further refined our analytic sample by excluding all Study members who received 
a diagnosis of schizophrenia by age 38 (N = 37). This step ensured that any observed 
associations between MDD and IQ were not driven by these individuals. 
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Of the remaining 920 Study members, 812 (88.3%) contributed 6 waves of mental health 
data, 67 (7.3%) contributed 5 waves of mental health data, 26 (2.8%) contributed 4 waves of 
mental health data, and 15 (1.6%) contributed 3 waves of mental health data. From ages 11 to 38, 
431 (46.9%) of these Study members received a diagnosis of major depressive disorder (MDD) 
at one or more assessment waves. These Study members constituted the “ever-depressed” group. 
The remainder of the cohort (N = 489, 53.2%) did not meet criteria for a diagnosis of MDD 
between the ages of 11 and 38. These Study members constituted the “never-depressed” group. 
Together, these groups composed the full analytic sample (Figure 1A). 
---Figure 1 Here--- 
As an initial test of the cognitive reserve hypothesis, we conducted a follow-forward 
analysis using a modified Poisson regression model with robust standard errors to estimate 
relative risk for the binary outcome of lifetime MDD (Zou, 2004). Methodologists have 
suggested that risk ratios are less inflated than odds ratios in situations where the outcome is 
common, which is the case for MDD in our sample (Cummings, 2009). The risk ratios presented 
can be understood as the ratio change in average risk of MDD for every one point increase in IQ. 
Using this approach, we found that risk of membership in the ever-depressed (N = 431; mean 
childhood IQ = 100.0, SD = 14.4) versus never-depressed group (N = 489; mean childhood IQ = 
101.4, SD = 13.8) did not differ as a function of childhood IQ, controlling for sex (IRR = 0.997; 
95% CI = 0.992, 1.002; p = 0.247). 
Previous studies have suggested that low childhood IQ is associated with an increased 
risk of developing not only depression, but also a number of other psychiatric conditions, 
including anxiety and substance use disorders (Fergusson, Horwood, & Ridder, 2005; Gale et al., 
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2008; Koenen et al., 2009; Rajput et al., 2011). Thus, it is possible that our ability to detect a 
predictive relationship between childhood IQ and lifetime depression is limited by the presence 
of other psychiatric disorders in the “never-depressed” group. Fortunately, one advantage 
afforded by the Dunedin Study’s repeated mental health assessments is that they allowed us to 
identify the small group of individuals who have never met criteria for any of the mental 
disorders assessed by the Study (hereafter referred to as the “enduring-mental-health” group; 
Schaefer et al., 2017), and to use these Study members as a new comparison group (N = 161 who 
had childhood IQ data; mean childhood IQ = 102.3, SD = 14.0) (Figure 1A). We thus conducted 
an additional follow-forward analysis to test whether childhood IQ was a significant predictor of 
membership in the ever-depressed versus enduring-mental-health groups, controlling for sex. 
Consistent with our previous results, we found that childhood IQ still did not appear to 
distinguish between the two groups (IRR = 0.997; 95% CI = 0.994, 1.001; p = 0.136). 
To provide a point of comparison, we also tested whether childhood IQ was a significant 
predictor of membership in the small group of Study members with schizophrenia (N = 37; mean 
childhood IQ = 94.0, SD = 17.6) versus the majority of the cohort who were never diagnosed 
with schizophrenia (N = 920; mean childhood IQ = 100.7, SD = 14.1), controlling for sex. Here, 
low childhood IQ was associated with higher risk of receiving a schizophrenia diagnosis (IRR = 
0.968; 95% CI = 0.944, 0.992; p = 0.010). 
Does lower IQ in childhood exert an effect on an individual’s later risk of developing Major 
Depressive Disorder independent of family-wide and genetic risk? 
An even more powerful approach to testing the cognitive reserve hypothesis is to 
compare two children growing up in the same family. If the cognitive reserve hypothesis is 
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correct, the sibling with higher IQ should be at lower risk of developing MDD. We tested this 
hypothesis in E-Risk Longitudinal Twin Study the using the following mixed-effects model: 
logit(πij) = β0+ βw(Xij - ?̅?i) + βB?̅?i 
In this specification, IQ effects are parsed into between-twin pair effects and within-twin pair 
effects using a logistic regression model, where i is used to index twin pairs and j represents 
individual twins within pairs, so πij and Xij represent, respectively, the probability of receiving a 
depression diagnosis and childhood IQ values for the jth twin of the ith pair, whereas ?̅?i represents 
the mean childhood IQ of both twins within the ith pair. The between-twin pair regression 
coefficient (βB) estimates whether pairs of twins with higher average age-12 IQ are at lower risk 
of being diagnosed with MDD at age 18. In contrast, the within-twin pair regression coefficient 
(βw) estimates whether the twin with higher IQ than his or her co-twin is less likely to be 
diagnosed with MDD than his or her co-twin. 
We first estimated this model using data from all available twin pairs (MZ and DZ) in E-
Risk. A significant between-twin-pair effect would reflect family-wide factors common to both 
twins that influence IQ and MDD and may underlie their association. A significant within-twin-
pair effect, on the other hand, would indicate that possessing low IQ in childhood predicts MDD 
independent of any factors that are shared between siblings growing up in the same family 
(Carlin et al., 2005). We then estimated this model using only the MZ twin pairs in the E-Risk 
Study. Because MZ twins are genetically identical, a significant within-twin pair effect would 
rule out the possibility that the association between IQ and MDD arises solely due to a shared 
genetic susceptibility that elevates risk of both phenotypes. 
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The parameters estimated from each of these models are reported in Table 1. Of the 
original 2,232 Study members, we included 2,003 (89.7%), excluding twins if they belonged to a 
twin pair in which (a) 1 or more twins lacked IQ data at age 12, or (b) both twins lacked mental 
health assessment data at age 18. Of these 2,003 Study members, 404 (20.2%) received a 
diagnosis of MDD. Both the full-cohort and MZ-twin-only models indicated that neither 
between-twin-pair nor within-twin-pair differences in IQ tested at age 12 appear to predict risk of 
MDD at age 18, consistent with our results from the follow-forward analysis conducted in the 
Dunedin Cohort. These findings did not support the assumption that lower IQ is causally related 
to increased risk of subsequent depression. 
---Table 1 Here--- 
Could lower IQ in childhood predict particularly early-onset or severe MDD? 
Although childhood IQ did not predict risk of future MDD in either cohort, it is still 
possible that a predictive relationship might exist between IQ in childhood and specific types of 
MDD, especially given previous research indicating a link between lower cognitive functioning 
and higher rates of relapse/recurrence, increased symptom severity, and impaired global 
functioning among depressed individuals (Jaeger et al., 2006; Majer et al., 2004; McDermott & 
Ebmeier, 2009). Thus, we next tested the hypotheses that childhood IQ would predict measures 
of MDD age-of-onset, persistence, self-rated impairment, number of diagnostic criteria endorsed, 
clinical attention, or psychiatric comorbidity in the Dunedin Cohort. 
Age of onset. We tested whether childhood IQ predicted an earlier age of depression 
onset by conducting a Cox proportional hazards regression using data from the full analytic 
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sample (N = 920), controlling for sex. We recorded the assessment wave during which each 
Study member in the ever-depressed group received his or her first diagnosis of MDD as the age 
of depression onset (M = 23.3, SD = 7.0, range = 15-38). We found that childhood IQ did not 
significantly predict depression age of onset (HR = 1.00; 95% CI = 0.99, 1.00; p = 0.381), 
indicating that Study members with low IQ did not appear to develop depression any earlier than 
Study members with higher IQ. 
Persistent course. We calculated depression recurrence/persistence for each Study 
member in the ever-depressed group (N = 431) as the proportion of waves during which that 
Study member met diagnostic criteria for MDD (Mproportion = 0.30, SD = 0.16, range = 0.17-1.00). 
We then conducted a linear regression that predicted the proportion of waves each Study member 
had received an MDD diagnosis as a function of childhood IQ, controlling for sex. We found no 
significant association between childhood IQ and this measure (b = -0.001; 95% CI: -0.002, 
0.000; t(428) = -1.31; p = 0.19), indicating that Dunedin Study members with low IQ who were 
diagnosed with MDD did not appear to spend significantly more Study waves suffering from 
depression than their higher-IQ peers with MDD. 
Self-rated impairment. Dunedin Study members were asked to rate the functional 
impairment caused by their depressive symptoms on a scale from 1 (some impairment) to 5 
(severe impairment) at each assessment wave between the ages of 18 and 38. We recorded self-
rated impairment in this cohort as the maximum impairment rating given between the ages of 18 
and 38 (M = 4.05, SD = 0.88, range = 2-5) by each Study member who met diagnostic criteria 
for MDD at least once during this same period (N = 412). We limited our analysis of impairment 
to this age range because self-ratings of impairment were not collected in earlier assessments. 
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We conducted a linear regression model predicting self-rated impairment as a function of 
childhood IQ, controlling for sex. We found that childhood IQ was a significant predictor of self-
rated impairment (b = -0.01; 95% CI: -0.01, 0.00; t(409) = -2.05; p = 0.041), suggesting that 
individuals with lower IQs who develop MDD tend to rate their depression as more impairing 
than their higher-IQ peers with MDD. Such an effect is likely to be of little practical 
significance, however, as each 1-point increase in IQ is associated with a predicted decrease of 
only 1/100th of a point on a 5-point self-rated impairment scale.  
Symptom count. We calculated symptom count as the number of MDD criteria endorsed 
by Study members between the ages of 18 and 38 (M = 15.03, SD = 7.78, range = 4-41) by each 
Study member who met diagnostic criteria for MDD at least once during this same period (N = 
413). We limited our analysis of symptom criteria to this age range because symptom count data 
from earlier waves were not available. 
We conducted a linear regression predicting symptom count between the ages of 18 and 
38 as a function of childhood IQ, controlling for sex. We found no significant association 
between childhood IQ and this measure (b = -0.02; 95% CI: -0.07, 0.03; t(410) = -0.86; p = 
0.392), suggesting that Study members with lower IQs tended to endorse a similar number of 
MDD symptoms relative to Study members with higher IQs. 
Clinical attention. Dunedin Study members reported if they had contacted a professional 
(i.e. a general practitioner, psychologist, or psychiatrist) for a mental health problem or received 
psychiatric medication between the ages of 20 and 38. Of the 350 Study members diagnosed 
with MDD during this same period in the full analytic sample (with present treatment contact 
data), 249 (71.1%) endorsed some form of treatment contact. We conducted a Poisson regression 
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model with robust standard errors to calculate risk ratios for the binary outcome of treatment 
contact as a function of childhood IQ, controlling for sex. We found no significant association 
between childhood IQ and this measure (IRR = 1.002; 95% CI: 0.997, 1.006; p = 0.464), 
suggesting that individuals with lower IQs who develop MDD were no more likely to receive 
treatment than their higher-IQ peers with MDD. 
Comorbidity. In the Dunedin Study, we operationalized comorbidity as the number of 
diagnostic families (including depressive disorders, anxiety disorders, substance use disorders, 
attention-deficit/hyperactivity disorder, and conduct disorder) represented in a Study member’s 
complete history of psychiatric diagnoses accumulated between the ages of 11 and 38 years (M = 
1.70, SD = 1.21, range 0-5 in the full analytic sample; M = 2.54, SD = 0.97, range 1-5 in the 
ever-depressed group). We did not include schizophrenia in our count of psychiatric 
comorbidities because Study members who developed schizophrenia were excluded from the 
analytic sample. 
We tested the association between childhood IQ and lifetime psychiatric comorbidity 
using a Poisson regression model that predicted the count of diagnostic families represented in 
each Study member’s diagnostic history between the ages of 11 and 38 as a function of 
childhood IQ, controlling for sex.  We found an association between childhood IQ and 
comorbidity in both the full analytic sample (N = 920; IRR = 0.993; 95% CI: 0.989, 0.996; p 
<0.001), and among ever-depressed Study members (N = 431; IRR = 0.995; 95% CI: 0.991, 
0.999; p = 0.025). 
Figure 2A charts mean IQ as a function of psychiatric comorbidity in the context of 
MDD. Here we plot IQ scores for Dunedin Study members who have never had depression, 
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Study members who have had depression only, and Study members who have had depression 
alongside 1 or more additional psychiatric conditions. Figure 2A shows that early IQ deficits 
were pronounced only among depressed Study members with multiple psychiatric comorbidities. 
Interestingly, Dunedin Study members with “pure” depression—that is, those who were 
diagnosed only with depression between the ages of 11 and 38 years—appeared to have slightly 
higher IQs in childhood than Study members who were never diagnosed with depression. We 
confirmed this observation through follow-forward analysis using Poisson regression, which 
indicated that Dunedin Study members with higher IQs were more likely to experience pure 
depression than no depression at all, controlling for sex (N = 543; IRR = 1.019; 95% CI = 1.001, 
1.037; p = 0.040). 
---Figure 2 Here--- 
Finally, we used modified Poisson regression with robust standard errors to test whether 
low childhood IQ predicted the emergence of certain types of lifetime psychiatric comorbidities, 
but not others. We found that children who went on to develop MDD (N = 420) with lower 
childhood IQs were also at increased risk of developing anxiety disorders (IRR = 0.993; 95% CI 
= 0.989, 0.996; p < 0.001), attention-deficit/hyperactivity disorder (IRR = 0.949; 95% CI = 
0.929, 0.969; p < 0.001), and conduct disorder (IRR = 0.983; 95% CI = 0.971, 0.996; p = 0.008), 
but not substance use disorders (IRR = 0.999; 95% CI = 0.993, 1.006; p = 0.861). 
II. The Scarring Hypothesis
Are individuals with a history of MDD more likely to show evidence of or report lingering 
cognitive impairment as adults? 
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 We next used data from the Dunedin Study to test for enduring cognitive deficits in 
previously-depressed Study members whose MDD had remitted by age 38, the time of adult 
cognitive assessment. Evidence of intellectual decline among these remitted individuals could be 
interpreted as evidence of a lingering depression-induced “scar” on cognitive functioning 
(Lewinsohn et al., 1981). For these analyses, we used data from 744 Study members who were 
assessed for mental disorder at age 38 but who did not meet criteria for a diagnosis of past-year 
MDD at age 38. This decision allowed us to separate the lingering cognitive “scarring” effects of 
a diagnostic history of MDD from the contemporaneous effects of a current episode of MDD. 
Similar to previous analyses, we also required these individuals to have (a) participated in at least 
half of the six mental health assessment waves from ages 11 to 38, (b) available childhood and 
adult IQ data, and (c) never received a diagnosis of schizophrenia. These individuals were 
divided into two groups: those with a previous history of MDD (N = 277; mean adult IQ = 101.2, 
SD = 14.4), and those with no previous history of MDD (N = 467; mean adult IQ = 101.0, SD = 
14.4) (Figure 1B).  
We conducted a series of one-way ANOVAs testing whether Study members with a 
previous history of MDD differed from Study members without such a history on age-38 IQ, 
self-reported cognitive functioning, or informant-reported cognitive functioning, controlling for 
sex. As shown in Table 2, we found that Study members with a history of depression scored 
lower on our subjective measures of cognitive functioning (i.e., self- and informant-report), but 
not on any of our objective measures of cognitive functioning (i.e. WISC-R and WAIS-IV IQ, IQ 
change from childhood to adulthood). Taken together, these results suggest that Study members 
with a history of depression were more likely to report that their cognitive functioning was 
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impaired despite little to no measurable change (on average) in objective cognitive functioning 
as assessed by IQ tests. 
---Table 2 Here--- 
Is there evidence of cognitive scarring following an episode of particularly severe or early-onset 
MDD? 
One criticism of the analyses summarized in Table 2 is that, in comparing only those 
individuals who were not depressed at age 38, we potentially ignore many of the most severe, 
chronic cases of MDD who continued to meet diagnostic criteria at the age-38 assessment wave. 
Consequently, we next tested whether any of our six clinical indicators (i.e., MDD age-of-onset, 
persistence/recurrence, self-rated impairment, number of diagnostic criteria endorsed, clinical 
attention, and comorbidity) predicted change in IQ from childhood (ages 7-11) to adulthood (age 
38). If cognitive scarring is more common following severe or early-onset cases of MDD, higher 
scores on these indicators should predict a more severe decline in IQ following a depressive 
episode. 
As shown in Table 3, only psychiatric comorbidity was found to predict a steeper decline 
in IQ from childhood to adulthood. This finding suggests that the cognitive scarring reported 
following a depressive episode may be more attributable to disorders commonly comorbid with 
MDD rather than the experience of a depressive episode per se. Figure 2B charts mean change 
in IQ between childhood (ages 7-11) and adult (age 38) assessments as a function of psychiatric 
comorbidity in the context of MDD, whereas Figure 2C does the same with each of our four 
subjective measures of cognitive functioning. Consistent with Figure 2A, Figures 2B and 2C 
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show that evidence of IQ decline and high subjective impairment was apparent only for 
depressed Study members with multiple psychiatric comorbidities. 
---Table 3 Here--- 
III. Beyond IQ
A second potential criticism of the analyses presented in this paper is that IQ is too crude 
or too global of a measure to detect the subtle changes in cognitive functioning associated with 
MDD. This may be particularly true for tests of the scarring hypothesis, as previous work has 
suggested that scarring is most noticeable in the domains of executive functioning (e.g., working 
memory, attention regulation, inhibitory control, and cognitive flexibility/switching) and long-
term memory (Bora et al., 2013; Rock et al., 2014). To address this concern, we selected from 
our datasets the measures most closely associated with these cognitive domains. A detailed 
description of these measures can be found in the Supplementary Materials. 
We first used Poisson regression with robust standard errors to test whether childhood 
scores on our neuropsychological measures were significant predictors of future MDD in the 
Dunedin Study, controlling for sex (a further test of the “cognitive reserve hypothesis”). Because 
Study members completed neuropsychological testing at age 13, we removed individuals who 
received a diagnosis of MDD during our first, juvenile assessment wave (ages 11 to 15) from the 
full analytic sample (shown in Figure 1A) in order to ensure that scores predicted future, rather 
than concurrent, MDD. As shown in Supplementary Table 1, the association between MDD 
status and performance on Trails B was marginally significant (IRR = 1.00; 95% CI: 1.00, 1.01; 
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p = 0.053), but otherwise we found little evidence to suggest that any of these measures 
significantly predicted future MDD risk.  
We next conducted a series of one-way ANOVAs testing whether Study members with a 
previous history of MDD differed from Study members without such a history on 
neuropsychological measures of executive functioning and memory administered at age 38, 
controlling for sex (a further test for cognitive scarring). As shown in Supplementary Table 2, 
Study members with a history of MDD scored significantly lower than Study members without 
such a history on a measure involving the delayed recall of multiple word pairs (WMS-IV Verbal 
Paired Associates) (F(1, 738) = 4.40, p = 0.036). However, this difference did not survive 
correction for multiple comparisons and no other significant between-group differences were 
observed. Viewed as a whole, our results provide little support for the notion that lower 
performance on measures of executive functioning or memory are predictors or enduring 
consequences of MDD.   
DISCUSSION 
Contrary to prior research, the present study found little evidence to suggest that low 
cognitive functioning is either a predictor or an enduring consequence of a major depressive 
episode. We repeatedly found that associations between cognitive functioning and MDD were 
evident only in the context of comorbid psychiatric diagnoses. The finding was true for both 
objective measures of cognitive functioning (i.e., WISC-R and WAIS-IV IQ, IQ change) and for 
self- and informant-reported indices of cognitive impairment. This pattern of findings suggests 
that, to the extent that evidence of cognitive reserve or cognitive scarring in MDD exists, it 
Cognitive Functioning and Depression 26 
seems to be largely attributable to psychiatric comorbidities rather than to depressive symptoms 
per se. 
The first hypothesis tested in the present study—the cognitive reserve hypothesis—
suggested that individuals with lower cognitive functioning in childhood would be at increased 
risk of developing MDD later in life. However, childhood IQ did not predict risk of future MDD 
between the ages of 11 and 38 in the Dunedin Study, even when we compared individuals who 
developed MDD to those who experienced no diagnosable psychopathology of any sort. 
Similarly, Study members’ performance on specific measures of memory and executive 
functioning at age 13 also did not predict future risk of MDD. In addition, we found no evidence 
that childhood IQ predicted MDD risk independent of family-wide and genetic risk when 
comparing E-Risk Study twins discordant for IQ. Together, these findings indicate that low IQ in 
childhood does not meaningfully increase risk of a depressive episode between early adolescence 
and midlife in these two cohorts from different eras and countries. 
The second hypothesis tested in this paper—the scarring hypothesis—suggests that the 
experience of MDD is associated with cognitive impairments that persist even after affective 
symptoms have remitted. Surprisingly, in remitted Study members we found little to no 
difference in mean childhood IQ, adult IQ, IQ change, or adult neuropsychological test scores 
between those with and without a past history of MDD, suggesting that the scarring effects of a 
depressive episode are not readily detected by these objective measures. However, we also found 
that those with an MDD history (and their informants) reported significantly greater subjective 
cognitive impairment than those without such a history. 
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The finding of greater subjective cognitive impairment in the context of no measurable 
objective deficit suggests at least two possible explanations. First, it is possible that any 
“lingering” cognitive impairments attributable to a history of MDD are largely subjective in 
nature. If this were true, the greater self-rated impairment reported by individuals with a history 
of MDD could reflect either (a) a tendency towards negative self-evaluation commonly seen in 
individuals vulnerable to depressive episodes, or (b) a form of the “good ol’ days bias,” in which 
individuals tend to view themselves as having been healthier (e.g., more cognitively advantaged) 
prior to a negative event (e.g., a depressive episode) (Iverson, Lange, Brooks, & Rennison, 
2010). The greater informant-rated impairment, in turn, could be caused by Study members 
communicating these beliefs to their informants. 
A second possibility, however, is that the cognitive deficits that either predispose 
individuals to depression or follow a depressive episode are contextual in nature. In other words, 
because formal cognitive testing is designed to measure patients’ optimal cognitive functioning 
under ideal conditions in the clinic, IQ and other neuropsychological tests may fail to capture 
genuine impairments that occur only under real-world conditions of high arousal, distraction, or 
affective distress in vulnerable individuals (i.e., those with a history of depression). The results 
of the present study do not, therefore, necessarily indicate that reports of cognitive impairment 
following a depressive episode are solely a product of patients’ cognitive distortions. 
Results presented here differ from those of ancillary analyses featured in previous papers 
that also used data from the Dunedin Study, which reported weak but statistically significant 
associations between IQ and MDD (Koenen et al., 2009; Meier et al., 2014). These papers, 
however, like others in the literature, did not control for comorbidity when estimating the 
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association between IQ and MDD. Moreover, the fact that results can differ even in the same 
sample speaks to the fact that correlations between IQ and MDD are ephemeral and depend 
heavily on a study’s analytical design and comparison groups. 
To some, the proportion of Dunedin Study members diagnosed with MDD may seem 
unusually high, raising concerns about the representativeness of our sample. However, we have 
shown elsewhere that (a) the past-year prevalence rates of mental disorders in the Dunedin 
cohort are similar to prevalence rates in nationwide surveys of the United States and of New 
Zealand (Moffitt et al., 2010) and (b) that lifetime prevalence estimates of Axis-I mental 
disorders in the Dunedin Study are comparable to estimates calculated in other cohorts with 
repeated psychiatric assessments (Schaefer et al., 2017). These observations indicate that the 
high lifetime prevalence rate of MDD reported here is due primarily to the advantage of our 
prospective assessment method rather than to an overabundance of mental disorder in New 
Zealand, or in this cohort. 
Despite the methodological advantages provided by our two cohorts, we acknowledge 
limitations. First, although our study features results from two independent samples, the E-Risk 
Study did not contain enough psychiatric assessment waves for us to replicate the analyses 
conducted using the Dunedin Cohort. Thus, it will be important to test the extent to which our 
findings generalize across different populations in future studies—particularly those findings that 
relate to lifetime history of disorder.  
Second, Study members were assessed for past-year (rather than current) depressive 
symptoms. Moreover, Dunedin Study members tend to schedule data collection when they feel 
well, reducing the likelihood of acute depressive symptoms on the day of cognitive testing. This 
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design feature meant that we were unable to control for baseline depressive symptoms at the time 
of cognitive assessment in our follow-forward analyses. However, given that no association was 
observed between childhood cognitive functioning and later MDD, it is unlikely that this would 
alter our conclusions. In addition, we were not able to examine the extent to which MDD was 
associated with short-term, contemporaneous decreases in cognitive functioning—an important 
question for future research.    
Third, assessment of mental disorder in the Dunedin cohort is both left- and right-hand 
censored, which means we cannot assess the relationship between IQ and episodes of MDD that 
occurred prior to age 11, or future cases that may onset after our most recent assessment at age 
38. This limitation means that we are not able to comment on the extent to which either 
childhood-onset or late-onset depression are associated with childhood IQ, or the extent to which 
such episodes might “scar” future cognitive functioning.  
 In spite of these limitations, our results have implications for the study and treatment of 
depression. In particular, they suggest that the persistent cognitive deficits commonly associated 
with MDD may not be attributable to depression per se, but rather to other psychiatric conditions 
that frequently co-occur with MDD (Kessler et al., 2003; Melartin et al., 2002). Previous studies 
comparing the premorbid IQs of individuals who developed MDD to those who did not have 
found individuals with MDD had premorbid IQs approximately 3 points lower than healthy 
controls (Sørensen, Sæbye, Urfer-Parnas, Mortensen, & Parnas, 2012), which is comparable to 
the effect of comorbidity reported in the present study. These findings also shed light on some of 
the questions highlighted in recent workshops hosted by the National Academies of Sciences 
(National Academies of Sciences, Engineering, and Medicine, 2015), and suggest that 
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researchers interested in treating the cognitive deficits associated with depression should perhaps 
widen their focus to consider alterations in fear-learning, attention, and executive functioning 
common to multiple disorders.  
Our results further suggest that investigators seeking to demonstrate the existence of 
cognitive impairment in the context of a particular disorder should carefully assess participants 
for current and past psychiatric comorbidities. This step allows investigators to distinguish 
between impairments that are attributable to the disorder of interest versus other, comorbid 
conditions or some shared, transdiagnostic process.  
Our findings also have implications for the prevention and treatment of MDD. Our 
finding that low childhood IQ does not appear to predict the development of MDD suggests that 
low IQ should not be considered a risk factor for MDD. Similarly, our finding that even the most 
severely disordered individuals (diagnosed with MDD and 3+ comorbidities) scored only about 5 
points lower, on average, than those with no history of depression, indicates that our ability to 
predict the course of any one person’s MDD based on premorbid intelligence is limited at best. 
Nevertheless, because subjective ratings of Study members’ cognitive impairment tended to 
increase with each additional psychiatric comorbidity, it may be helpful to screen individuals 
who report ongoing cognitive impairment following a depressive episode for past and current 
anxiety, substance-use, attention-deficit, or psychotic disorders. In addition, such patients may 
benefit from cognitive therapy that examines the function and impact of beliefs of cognitive 
impairment, as well as therapies aimed at regulating affect and managing psychiatric symptoms, 
which may continue to impact cognitive functioning in certain contexts (e.g., when multi-tasking 
or under conditions of high emotional arousal).  
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In summary, we find that cognitive deficits are neither an antecedent nor enduring 
consequence of MDD, absent psychiatric comorbidities. Thus, future research that seeks to 
assess and treat cognitive scarring in the context of psychiatric illness would be wise to 
investigate psychopathology broadly rather than MDD specifically. In addition, rather than 
focusing on cognitive impairment as a risk factor for MDD or a lingering consequence of the 
disorder, our results suggest that treatment and prevention efforts should focus on evaluating—
and perhaps treating—cognitive deficits that co-occur with depressive symptoms. We hope that 
our findings will inform studies aiming to develop treatments for these impairments, as well as 
spur additional research dedicated to better understanding the complex interplay between 
affective symptoms and cognitive functioning in the individuals who suffer from this disorder. 
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Table 1. Testing the “cognitive reserve” hypothesis: Between- and within-twin pair effects 
of childhood IQ on risk of depression at age 18 in the E-Risk Cohort 
Effects 
All Twins (N = 2,003) MZ Twins (N = 1,124) 
RR (95% CI) p RR (95% CI) P 
βB 1.00 (0.99-1.00) 0.279 1.00 (0.99-1.01) 0.685 
βw 1.00 (0.99-1.01) 0.720 0.99 (0.97-1.01) 0.344 
Notes. βB represents the between-pair effects of mean childhood IQ (assessed at age 12) on risk 
of depression at age 18. βw represents the effect of within-pair differences in childhood IQ, 
controlling for the effects of shared family environment and (in MZ twins) genetics. Sex was 
included in each model as a covariate. 
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Table 2. Testing the “scarring hypothesis”: Cognitive functioning in Study members who were not diagnosed with past-year 
MDD at age 38, by lifetime diagnostic history. 
Measure (Age at Assessment) 
No History of MDD Past History of MDD 
N Mean (95% CI) N Mean (95% CI) F p 
Objective Measures 
  WISC IQ (Age 7-11) 277 101.3 (99.8, 102.9) 467 101.6 (100.4, 102.8) 0.02 0.897 
  WAIS IQ (Age 38) 277 101.2 (99.5, 102.9) 467 101.0 (99.7, 102.3) 0.23 0.631 
  IQ Change 277 -0.14 (-1.27, 0.99) 467 -0.62 (-1.44, 0.20) 0.31 0.577 
Subjective Measures 
  Self-Reported 
  Cognitive Complaints (Age 38) 277 0.11 (-0.01, 0.22) 467 -0.21 (-0.29, -0.13) 13.99 <0.001 
  Impairment (Age 38) 277 0.04 (-0.07, 0.16) 467 -0.20 (-0.27, -0.13) 13.33 <0.001 
  Informant-Reported 
  Memory Problems (Age 38) 275 -0.02 (-0.13, 0.10) 460 -0.15 (-0.22, -0.07) 7.08 0.008 
  Attention Problems (Age 38) 275 -0.04 (-0.15, 0.07) 460 -0.15 (-0.23, -0.07) 6.04 0.014 
Notes. This table includes only those Study members who (a) were not diagnosed with past-year MDD at age 38 and (b) had present 
data for adult IQ. The “no history of MDD” group represents Study members who had never met criteria for MDD. The “past history 
of MDD” group represents Study members who had met diagnostic criteria for MDD during a previous wave but no longer met 
criteria at age 38. Scores on objective measures are reported as IQ points (mean = 100, SD = 15). Scores on subjective measures were 
standardized in the full cohort to a mean of 0 and a standard deviation of 1. Means were compared across diagnostic groups through a 
series of one-way ANOVAs, controlling for sex.  
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Tables 3. Testing the “scarring hypothesis”: Change in IQ points from childhood to adulthood per standard deviation increase 
in each clinical indicator among Study members diagnosed with MDD.  
Clinical Indicators 
Change in IQ 
b (SE) b (SE) b (SE) b (SE) b (SE) b (SE) 
Age of onset -0.06 
(-1.01, 0.88) 
Persistence/Recurrence 0.11 
(-1.02, 1.24) 
Self-rated impairment -0.33 
(-1.29, 0.63) 
# of Symptom Criteria -0.29 
(-1.40, 0.82) 
Clinical Attention 0.26 
(-0.89, 1.41) 
Psychiatric Comorbidity -2.41 ***
 (-3.68, -1.15) 
Notes. This table displays coefficients and 95% confidence intervals from a series of separate regression equations predicting change 
in IQ from childhood (assessed at ages 7-11) to adulthood (age 38) as a function of each clinical indicator, controlling for sex. Ns for 
each regression ranged from 347 to 414. Clinical indicators were standardized to a mean of 0 and a standard deviation of 1 in the full 
cohort to facilitate comparison across indicators. 
*** = p < 0.001 
SUPPLEMENTARY MATERIALS TO SCHAEFER ET AL.,  
IS LOW COGNITIVE FUNCTIONING A PREDICTOR OR CONSEQUENCE OF MAJOR 
DEPRESSIVE DISORDER? A TEST IN TWO LONGITUDINAL BIRTH COHORTS 
These Supplementary Materials contain additional details about the neuropsychological 
tests administered at ages 13 and 38 in the Dunedin Study. In addition, they contain 
supplemental tables to accompany the results of statistical analyses reported in the main article. 
Measures of neuropsychological functioning 
All testing occurred in the morning in two 50-min counterbalanced sessions. Dunedin 
Study members completed a small number of neuropsychological measures at age 13, and then a 
larger battery at age 38.  
Neuropsychological functioning at age 13 years. 
We assessed executive functioning with the following test: 
Trails-B is a test of scanning and tracking, divided attention, and mental flexibility, which 
involves drawing lines to connect consecutively numbered and lettered circles, alternating 
between numbers and letters. Scores represent the time, in seconds, to complete the test. Lower 
scores are better (Army Individual Test Battery, 1944). Test-retest reliability=0.73-0.89.  
We assessed memory with the following tests: 
Rey Auditory Verbal Learning Test: Total Recall is a test of verbal learning and memory 
that involves a five-trial presentation of a 15-word list and a one- time presentation of an 
interference list. Four trials of the 15-word list were administered due to time constraints. The 
Total Recall indexes the total number of words (0–60) recalled over four trials (the sum of words 
recalled across trials 1–4). Higher scores are better (Lezak, 2004); Test-retest reliability=0.86. 
Rey Auditory Verbal Learning Test: Delayed Recall indexes the total number of words 
from the original list (0–15) recalled after a 25–30 minute delay. Higher scores are better (Lezak, 
2004). Test-retest reliability=0.80.  
Neuropsychological functioning at age 38 years. 
We assessed executive functioning with the following tests: 
CANTAB Rapid Visual Information Processing: A‘ (A-prime), is a signal-detection 
measure that taps sustained attention, often called attentional vigilance. The participant scans for 
a 3-digit target sequence in a digit stream that is ongoing for 7 minutes, and responds whenever a 
target sequence is spotted. At the most difficult level, the participant scans simultaneously for 
two target sequences. Higher scores are better (Sahakian & Owen, 1992); Test-retest 
reliability=0.76. 
CANTAB Rapid Visual Information Processing: Total False Alarms records impulsive 
jumping to respond too soon before the correct target digit sequence is complete. Because 
relatively few participants made numerous false alarms, this measure is categorical, coded 
0=none, 1=1 false alarm, 2=2 or more false alarms. Lower scores are better (Sahakian & Owen, 
1992); Test-retest reliability not available.  
WAIS Working Memory Index was derived from the Arithmetic and Digit-span subtests. 
The Arithmetic subtest of WAIS requires working memory processes to be applied to orally 
presented verbal information. It involves numerical knowledge, short-term memory, attention, 
and concentration. Arithmetic problems are presented in story format. Performance requires 
holding information in short-term memory, accessing long-term memory to retrieve numerical 
rules of mathematical operation, and using the rules to manipulate the stored data. Items are 
arranged according to the level of difficulty and have time limits. The Digit-span subtest of 
WAIS is a test of memory span, attention/concentration, and ability to mentally manipulate 
information. The test requires listening to a sequence of digits read aloud and repeating them in 
forward, backward, and ascending order. Digit sequences range in length from 2 to 9 digits and 
are presented in order of difficulty. Higher scores on the WAIS Working Memory Index are 
better (Wechsler, 2008); Test-retest Reliability=0.90 
Wechsler Memory Scale-III: Months of the Year Backwards Test is a test of attention and 
tracking. It requires reciting the months of the year in backwards order, starting with December. 
Responses were scored according to the instructions in the WMS-III manual. Scores ranged from 
1 (poor performance) to 5 (good performance) and reflect both accuracy and speed. Higher 
scores are better (Wechsler, 1997); Test-retest Reliability=0.80  
Trails-B is a test of scanning and tracking, divided attention, and mental flexibility, which 
involves drawing lines to connect consecutively numbered and lettered circles, alternating 
between numbers and letters. Scores represent the time, in seconds, to complete the test. Lower 
scores are better (Army Individual Test Battery, 1944). Test-retest reliability=0.73-0.89.  
We assessed memory with the following tests: 
CANTAB Paired Associates Learning: First Trial Memory Score is a test of visual 
memory and new learning. Boxes are displayed on the screen and are opened in a random order. 
One or more of them will contain a pattern. The patterns are then displayed in the middle of the 
screen, one at a time, and the subject must touch the box where the pattern was originally 
located. If the subject makes an error, the patterns are re-presented to remind the subject of their 
locations. The difficulty level increases through the test. The number of patterns increases across 
eight stages (i.e., two 1-pattern stages, two 2-pattern stages, two 3-pattern stages, one 6-pattern 
stage, one 8-pattern stage), which challenges even very able subjects. For each stage, up to 10 
trials are presented until all the patterns are located correctly. For the First Trial Memory Score, 
the number of patterns correctly located after the first trial of each stage is summed across the 
stages completed (range 0–26, with 26 meaning that all the patterns were correctly located for all 
stages the first time). Higher scores are better (Sahakian & Owen, 1992); Test-retest 
reliability=0.87. 
CANTAB Paired Associates Learning: Total Errors is based on the same protocol as 
above but considers the total number of errors (with an adjustment for each stage not attempted 
due to previous failure). Lower scores are better (Sahakian & Owen, 1992); Test-retest 
reliability=0.64. 
Wechsler Memory Scale-III: Verbal Paired Associates Total Recall is a test of verbal 
learning and memory. Eight pairs of unrelated words (e.g., hat-sofa) are read aloud and followed 
by a recall task (one of the words from each word pair is given, and the associated word must be 
recalled). Four trials of the eight word-pairs are presented. Presentation of the word-pairs is 
randomized across trials. The total recall score represents the total number of words (0–32) 
recalled across four trials. Higher scores are better (Wechsler, 1997); Test-retest reliability=0.75. 
Wechsler Memory Scale-III: Verbal Paired Associates Delayed Recall is based on the 
same protocol as above but represents the total number of words (0–8) recalled after a 25–35 
minute delay. Higher scores are better (Wechsler, 1997); Test-retest reliability=0.73. 
Rey Auditory Verbal Learning Test: Total Recall is a test of verbal learning and memory 
that involves a five-trial presentation of a 15-word list and a one- time presentation of an 
interference list. Four trials of the 15-word list were administered due to time constraints. The 
Total Recall indexes the total number of words (0–60) recalled over four trials (the sum of words 
recalled across trials 1–4). Higher scores are better (Lezak, 2004); Test-retest reliability=0.86. 
Rey Auditory Verbal Learning Test: Delayed Recall indexes the total number of words 
from the original list (0–15) recalled after a 25–30 minute delay. Higher scores are better (Lezak, 
2004). Test-retest reliability=0.80.  
Table S1. Testing the “cognitive reserve hypothesis”: Neuropsychological test performance of Study members who did and did 
not receive a diagnosis of MDD by age 38. 
Measures (All Administered at Age 13) 
Never Depressed Ever Depressed Poisson Regression 
Results 
N Mean (95% CI) N Mean (95% CI) IRR (95% CI) p 
Executive Functioning 
          Trails B (time in seconds) 368 35.5 (33.6, 37.3) 286 37.5 (35.5, 39.4) 1.00 (1.00, 1.01) 0.053 
Memory 
          Rey Auditory Verbal Learning Test -- Total words recalled 375 40.6 (39.9, 41.3) 290 41.3 (40.5, 42.1) 0.99 (0.96, 1.02) 0.551 
          Rey Auditory Verbal Learning Test -- Delayed recall 374 9.9 (9.7, 10.2) 289 10.0 (9.7, 10.4) 1.00 (0.99, 1.01) 0.733 
Notes. This table includes Study members from the full analytic sample (see Figure 1A) who completed neuropsychological testing at 
age 13. To ensure that cognitive functioning at age 13 was being used to predict future MDD, Study members who received a 
diagnosis of MDD prior to age 18 were excluded from this analysis. The “Never Depressed” group represents Study members who did 
not ever meet criteria for MDD between the ages of 18 and 38. The “Ever Depressed” group represents Study members who did meet 
diagnostic criteria for MDD during this same period. Relative risk (IRR) of MDD was calculated using a modified Poisson regression 
model with robust standard errors (Zou, 2004). Significant group differences (p < 0.05) are shown in bold. 
Table S2: Testing the “scarring hypothesis”: Neuropsychological test performance of Study members who were not diagnosed 
with past-year MDD at age 38, by lifetime diagnostic history. 
Measures (All Administered at Age 38) 
Never Depressed Ever Depressed 
N Mean (95% CI) N Mean (95% CI) F p 
Executive Functioning 
          Rapid Visual Processing -- A prime 271 0.91 (0.91, 0.92) 458 0.91 (0.91, 0.92) 0.01 0.916 
          Rapid Visual Processing -- False alarms 271 0.23 (0.18, 0.30) 460 0.25 (0.20, 0.30) 0.11 0.743 
          WAIS-IV Working Memory Index  277 103.5 (101.6, 105.4) 467 104.4 (103.0, 105.7) 0.03 0.867 
          WMS-III Months of the Year Backwards 276 3.12 (2.96, 3.28) 467 3.12 (3.00, 3.25) 1.93 0.165 
          Trails B (time in seconds) 277 63.9 (61.5, 66.3) 466 63.4 (61.6, 65.2) 0.81 0.367 
Memory 
          CANTAB Paired Associates -- First Trial 273 20.2 (19.8, 20.7) 460 20.3 (20.0, 20.6) 0.21 0.649 
          CANTAB Paired Associates -- Total Errors 273 12.3 (9.8, 14.8) 461 11.0 (9.8, 12.1) 1.83 0.176 
          Verbal Paired Associates -- Total N correct 276 17.1 (16.1, 18.1) 467 15.6 (14.9, 16.4) 3.07 0.080 
          Verbal Paired Associates -- Delayed recall total 276 5.6 (5.3, 5.9) 465 5.1 (4.8, 5.3) 4.40 0.036 
          Rey Auditory Verbal Learning Test -- Total words recalled 275 38.7 (37.8, 39.6) 467 37.1 (36.4, 37.8) 1.32 0.252 
          Rey Auditory Verbal Learning Test -- Delayed recall 276 9.4 (9.1, 9.8) 467 9.0 (8.7, 9.3) 0.11 0.745 
Notes. This table includes only those Study members who (a) completed neuropsychological testing at age 38, (b) were not diagnosed 
with past-year MDD at age 38 and (b) had present data for adult IQ. The “no history of MDD” group represents Study members who 
had never met criteria for MDD. The “past history of MDD” group represents Study members who had met diagnostic criteria for 
MDD during a previous wave but no longer met criteria at age 38. Means were compared across diagnostic groups through a series of 
one-way ANOVAs, controlling for sex. Significant group differences (p < 0.05) are shown in bold. 
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